Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.51
-0.49 (-3.50%)
At close: Feb 20, 2026, 4:00 PM EST
13.65
+0.14 (1.04%)
After-hours: Feb 20, 2026, 5:21 PM EST

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.62M in the quarter ending December 31, 2025, with 9.76% growth. This brings the company's revenue in the last twelve months to $66.98M, up 0.58% year-over-year. In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%.

Revenue (ttm)
$66.98M
Revenue Growth
+0.58%
P/S Ratio
5.85
Revenue / Employee
$558,167
Employees
120
Market Cap
392.05M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
REGENXBIO161.32M
Niagen Bioscience124.71M
Century Therapeutics113.34M
Entrada Therapeutics61.52M
Assembly Biosciences37.19M
PureTech Health6.39M
Immutep3.31M
Absci2.82M
Revenue Rankings

ENTA News

More News